Finance
Markets

ABT

stock NYSE
Abbott Laboratories
$87.77 -0.61 (-0.69%) At close

Key stats

The day open and close within the day's range
Low $86.83 High $88.60
Open
$88.60
+0.25%
Close
$87.77
-0.69%
52-week range where the price sits across its year
52w low $81.97 52w high $139.06
Current
$87.77
Prev close
$88.38
Volume 0.71× the 3-month average
0 avg 2× avg
Today
8.52M
3-mo avg
12.05M

Fundamentals

Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.

P/E ratio Strong
23.6x

At 24x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
2.73%

A 2.7% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
14.7%

A 14.7% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
12.5%

A 12.5% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
7.5%

A 7.5% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
·

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.58

At 1.58, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+5.7%

Revenue grew 5.7% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-51.3%

Net income fell 51.3% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financials

FY2021FY2022FY2023FY2024FY2025
Revenue $43.1B$43.7B$40.1B$42.0B$44.3B
Net income $7.1B$6.9B$5.7B$13.4B$6.5B
Diluted EPS $3.94$3.91$3.26$7.64$3.72
Dividend / share ·$1.92$2.08$2.24$2.40
Total assets $75.2B$74.4B$73.2B$81.4B$86.7B
Total liabilities ·····
Shareholder equity $35.8B$36.7B$38.6B$47.7B$52.1B

Recent SEC filings